Provider preferences for delivery of HIV care coordination services: results from a discrete choice experiment.

Provider preferences for delivery of HIV care coordination services: results from a discrete choice experiment.
复制标题

DOI:
10.1002/jia2.25887
复制
发表时间:
2022-03
影响因子:
6
通讯作者:
Irvine M
Irvine M
中科院分区:
医学1区
文献类型:
--
作者:
Zimba R;Fong C;Conte M;Baim-Lance A;Robertson M;Carmona J;Gambone G;Nash D;Irvine M

文献摘要

参考文献

被引文献

相似文献

PROMISE研究于2018年启动,旨在评估和记录现有艾滋病毒护理协调计划(CCP)的变更实施情况,该计划旨在解决纽约市艾滋病毒感染者在护理和治疗参与方面的持续差异。我们评估了供应商对CCP功能的认可,以了解参与该计划的驱动因素。我们使用离散选择实验来衡量提供者对CCP四个属性的认可,包括:(1)CCP如何帮助药物依从性,(2)CCP如何帮助初级保健预约,(3)CCP如何帮助初级保健以外的问题,以及(4)CCP访问发生的地方(访问位置)。每一种属性都有三四个层次。我们的主要结果是相对重要性和部分价值效用,四个CCP计划属性水平的偏好度量,使用分层贝叶斯多项logit模型估计。来自25个修订后的CCP执行机构的核心CCP职位(患者导航员,护理协调员和项目主任或其他管理人员)的所有非医疗提供者都有资格参与。我们收到了来自152个供应商的回复,其中68%被确定为女性,49%被确定为拉丁美洲人/a,34%被确定为黑人,60%为30-49岁。拜访位置(28.6%,95%置信区间[CI] 27.0-30.3%)的相对重要性最高,其次是工作人员如何帮助坚持ART(24.3%,95% CI 22.4-26.1%),工作人员如何帮助解决初级保健以外的问题(24.2%,95% CI 22.7-25.7%)以及工作人员如何帮助初级保健预约(22.9%,95% CI 21.7-24.1%)。在上述每个属性中,分别具有最高部分价值效用的水平是距离计划或机构60分钟的家访(效用19.9,95% CI 10.7-29.0),直接观察治疗(效用26.1,95% CI 19.1-33.1),帮助非HIV专业医疗护理(效用26.5,95% CI 21.5-31.6)和提醒客户并陪同他们进行初级保健预约(效用20.8,95% CI 15.6-26.0)。正在进行的CCP改进应考虑如何最好地支持和评估本研究中提供商认可的密集CCP组件。
The PROMISE study was launched in 2018 to assess and document the implementation of changes to an existing HIV Care Coordination Programme (CCP) designed to address persistent disparities in care and treatment engagement among persons with HIV in New York City. We evaluated provider endorsement of features of the CCP to understand drivers of engagement with the programme. We used a discrete choice experiment to measure provider endorsement of four CCP attributes, including: (1) how CCP helps with medication adherence, (2) how CCP helps with primary care appointments, (3) how CCP helps with issues other than primary care and (4) where CCP visits take place (visit location). Each attribute had three to four levels. Our primary outcomes were relative importance and part‐worth utilities, measures of preference for the levels of the four CCP program attributes, estimated using a hierarchical‐Bayesian multinomial logit model. All non‐medical providers in the core CCP positions of patient navigator, care coordinator and programme director or other administrator from each of the 25 revised CCP‐implementing agencies were eligible to participate. We received responses from 152 providers, 68% of whom identified as women, 49% identified as Latino/a, 34% identified as Black and 60% were 30–49 years old. Visit location (28.6%, 95% confidence interval [CI] 27.0–30.3%) had the highest relative importance, followed by how staff help with ART adherence (24.3%, 95% CI 22.4–26.1%), how staff help with issues other than primary care (24.2%, 95% CI 22.7–25.7%) and how staff help with primary care appointments (22.9%, 95% CI 21.7–24.1%). Within each of the above attributes, respectively, the levels with the highest part‐worth utilities were home visits 60 minutes from the program or agency (utility 19.9, 95% CI 10.7–29.0), directly observed therapy (utility 26.1, 95% CI 19.1–33.1), help with non‐HIV specialty medical care (utility 26.5, 95% CI 21.5–31.6) and reminding clients about and accompanying them to primary care appointments (utility 20.8, 95% CI 15.6–26.0). Ongoing CCP refinements should account for how best to support and evaluate the intensive CCP components endorsed by providers in this study.
DOI: 10.1016/s0140-6736(10)60936-1
发表时间: 2010-08-14
期刊: LANCET
影响因子: 168.9
作者:
Montaner, Julio S. G.;Lima, Viviane D.;Barrios, Rolando;Yip, Benita;Wood, Evan;Kerr, Thomas;Shannon, Kate;Harrigan, P. Richard;Hogg, Robert S.;Daly, Patricia;Kendall, Peny
通讯作者: Kendall, Peny
DOI: 10.1371/journal.pone.0012598
发表时间: 2010-09-13
期刊: PloS one
影响因子: 3.7
作者:
Lingappa JR;Hughes JP;Wang RS;Baeten JM;Celum C;Gray GE;Stevens WS;Donnell D;Campbell MS;Farquhar C;Essex M;Mullins JI;Coombs RW;Rees H;Corey L;Wald A;Partners in Prevention HSV/HIV Transmission Study Team
通讯作者: Partners in Prevention HSV/HIV Transmission Study Team
DOI: 10.1186/2191-1991-3-30
发表时间: 2013-12-18
影响因子: 2.4
作者:
Mühlbacher AC;Stoll M;Mahlich J;Nübling M
通讯作者: Nübling M
DOI: 10.1016/j.jval.2010.11.013
发表时间: 2011-06-01
期刊: VALUE IN HEALTH
影响因子: 4.5
作者:
Bridges, John F. P.;Hauber, A. Brett;Mauskopf, Josephine
通讯作者: Mauskopf, Josephine